Oralni aparati za lečenje sindroma prekida disanja tokom spavanja
Scindeks Asistent Scindeks Asistent

Kako citirati

1.
Kopitović I, Pjevac S, Mirić M, Miličić D, Vukoja M. Oralni aparati za lečenje sindroma prekida disanja tokom spavanja. Vojnosanit Pregl [Internet]. 21. Juni 2017. [citirano 21. Septembar 2026.];74(3):273-7. Dostupno na: https://test.aseestant.ceon.rs/index.php/vsp/article/view/VSP150430179K

Ključne reči

sleep apnea
obstructive||
||apneja u snu
opstruktivna
orthodontic appliances||
||ortodontski aparati
treatment outcome||
||lečenje
ishod
DOI: 10.2298/VSP150430179K

Reference

Kopitović I. Respiratory disorders during sleep. Novi Sad: Facul-ty of Medicine, University of Novi Sad; 2011. (Serbian)

Kopitovic I, Trajanovic N, Prodic S, Drvenica MJ, Ilic M, Kuruc V, et al. The Serbian version of the Epworth Sleepiness Scale. Sleep Breath 2011; 15(4): 775−80.

Tkacova R, Dorkova Z. Clinical presentations of OSA in adults. Eur Respir Mon 2010; 50: 86−103.

Itasaka Y, Miyazaki S, Ishikawa K, Togawa K. Intensity of snor-ing in patients with sleep-related breathing disorders. Psychia-try Clin Neurosci 1999; 53(2): 299−300.

Lavie L. Oxidative stress and inflammation in OSA. Eur Respir Mon 2010; 50: 360−80.

Almendros I, Montserrat JM, Ramírez J, Torres M, Duran-Cantolla J, Navajas D, et al. Intermittent hypoxia enhances cancer pro-gression in a mouse model of sleep apnoea. Eur Respir J 2012; 39(1): 215−7.

Shamsuzzaman A, Amin RS, Calvin AD, Davison D, Somers VK. Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients. Sleep Breath 2014; 18(4): 761−6.

Bonsignore MR, Battaglia S, Zito A, Lombardi C, Parati G. Sleep apnoea and systemic hypertension. Eur Respir Mon 2010; 50: 150−73.

Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G. Obstructive Sleep Apnea and Risk of Cardiovascular Events and All-Cause Mortality: A Decade-Long Historical Cohort Study. PLoS Med 2014;11(2) e1001599.

Gami AS, Olson EJ, Shen WK, Wright SR, Ballman KV, Hodge DO, et al. Obstructive sleep apnea and the risk of sudden car-diac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 2013; 62(7): 610−6.

Kopitović I, Anđelić B, Jovančević-Drvenica M. Comparing parame-ters of screening polysomography and excessive day time sleepiness in sleep apnea syndrome. Scr Med 2008; 1(39): 9−12. (Serbian)

Kopitovic I, Kojicic M, Drvenica JM, Ilic M. Laba in patients with stage 1 COPD and mild sleep apnea: A pilot study. Cent Eur J Med 2011; 6(1): 26−30.

Kopitović I, Jovančević-Drvenica M, Vukoja M, Okiljević Z. Breathing disorder during sleep. Časopis udruženja pulmologa Republike Srpske 2011; 11(1): 310−5. (Serbian)

Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insu-lin resistance: The Sleep Heart Health Study. Am J Epidemiol 2004; 160(6): 521−30.

Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome. Am J Respir Crit Care Med 2010; 182(3): 325−31.

Byrne TJ, Parish JM, Somers V, Aqel BA, Rakela J. Evidence for liver injury in the setting of obstructive sleep apnea. Ann Hepatol 2012; 11(2): 228−31.

Durgan DJ, Bryan RM. Cerebrovascular consequences of ob-structive sleep apnea. J Am Heart Assoc 2012; 1(4): e000091.

Harris M, Glozier N, Ratnavadivel R, Grunstein RR. Obstructive sleep apnea and depression. Sleep Med Rev 2009; 13(6): 437−44.

Hoffstein V. Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath 2007; 11(1): 1−22.

Gaudette E, Kimoff RJ. Pathophysiology of OSA. Eur Respir Monogr 2010; 50: 31−50.

Kuna S, Remmers JE. Anatomy and physiology of upper airway obstruction. In: Kryger MH, Roth T, Dement WC, editors. Prin-ciples and Practice of Sleep Medicine. 3rd ed. London: WB Saunders; 2000. p. 840−58.

Verbraecken JA, De Backer WA. Upper airway mechanics. Res-piration 2009; 78(2): 121−33.

Randerath WJ, Verbraecken J, Andreas S, Bettega G, Boudewyns A, Hamans E, et al. Non-CPAP therapies in obstructive sleep ap-noea. Eur Respir J 2011; 37(5): 1000−28.

Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of ob-structive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1(8225): 862−5.

Cartwright RD, Samelson CF. The effects of a nonsurgical treat-ment for obstructive sleep apnea. The tongue-retaining device. JAMA 1982; 248(6): 705−9.

Fleetham JA, Almeida FR. Oral appliances. Eur Respir Mon 2010; 50: 267−85.

Cistulli PA, Gotsopoulos H, Marklund M, Lowe AA. Treatment of snoring and obstructive sleep apnea with mandibular reposi-tioning appliances. Sleep Med Rev 2004; 8(6): 443−57.

Ng AT, Gotsopoulos H, Qian J, Cistulli PA. Effect of oral appli-ance therapy on upper airway collapsibility in obstructive sleep apnea. Am J Respir Crit Care Med 2003; 168(2): 238−41.

Kyung SH, Park Y, Pae E. Obstructive sleep apnea patients with the oral appliance experience pharyngeal size and shape changes in three dimensions. Angle Orthod 2005; 75(1): 15−22.

Gale DJ, Sawyer RH, Woodcock A, Stone P, Thompson R, Brien OK. Do oral appliances enlarge the airway in patients with obstruc-tive sleep apnoea? A prospective computerized tomographic study. Eur J Orthod 2000; 22(2): 159−68.

Sanner BM, Heise M, Knoben B, Machnick M, Laufer U, Kikuth R, et al. MRI of the pharynx and treatment efficacy of a mandibular advancement device in obstructive sleep apnoea syndrome. Eur Respir J 2002; 20(1): 143−50.

Chan AS, Sutherland K, Schwab RJ, Zeng B, Petocz P, Lee RW, et al. The effect of mandibular advancement on upper airway structure in obstructive sleep apnoea. Thorax 2010; 65(8): 726−32.

Ryan CF, Love LL, Peat D, Fleetham JA, Lowe AA. Mandibular advancement oral appliance therapy for obstructive sleep ap-noea: effect on awake calibre of the velopharynx. Thorax 1999; 54(11): 972−7.

Lazard DS, Blumen M, Lévy P, Chauvin P, Fragny D, Buchet I, et al. The tongue-retaining device: efficacy and side effects in ob-structive sleep apnea syndrome. J Clin Sleep Med 2009; 5(5): 431−8.

Naismith SL, Winter VR, Hickie IB, Cistulli PA. Effect of oral appliance therapy on neurobehavioral functioning in obstruc-tive sleep apnea: a randomized controlled trial. J Clin Sleep Med 2005; 1(4): 374−80.

Barnes M, McEvoy DR, Banks S, Tarquinio N, Murray CG, Vowles N, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170(6): 656−64.

Gotsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy re-duces blood pressure in obstructive sleep apnea: a ran-domized, controlled trial. Sleep 2004; 27(5): 934−41.

Yoshida K. Effect on blood pressure of oral appliance therapy for sleep apnea syndrome. Int J Prosthodont 2006; 19(1): 61−6.

Hoekema A, Voors AA, Wijkstra PJ, Stegenga B, Hoeven JH, Tol CG, et al. Effects of oral appliances and CPAP on the left ven-tricle and natriuretic peptides. Int J Cardiol 2008; 128(2): 232−9.

Trzepizur W, Gagnadoux F, Abraham P, Rousseau P, Meslier N, Saumet J, et al. Microvascular endothelial function in obstruc-tive sleep apnea: Impact of continuous positive airway pres-sure and mandibular advancement. Sleep Med 2009; 10(7): 746−52.

Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G. The ef-fects of 1-year treatment with a herbst mandibular advance-ment splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 2007; 131(3): 740−9.

Coruzzi P, Gualerzi M, Bernkopf E, Brambilla L, Brambilla V, Broia V, et al. Autonomic cardiac modulation in obstructive sleep apnea: effect of an oral jaw-positioning appliance. Chest 2006; 130(5): 1362−8.

White D, Shafazand S. Mandibular Advancement Device vs CPAP in the Treatment of Obstructive Sleep Apnea: Are they Equally Effective in Short Term Health Outcomes. J Clin Sleep Med 2013; 9(9): 2013−5.

Mehta A, Qian J, Petocz P, Darendeliler MA, Cistulli PA. A ran-domized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med 2001; 163(6): 1457−61.

Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002; 166(5): 743−8.

Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral ap-pliances for snoring and obstructive sleep apnea: A review. Sleep 2006; 29(2): 244−62.

Ferguson KA, Ono T, Lowe AA, al-Majed S, Love LL, Fleetham JA. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997; 52(4): 362−8.

Estrange LP, Battagel JM, Harkness B, Spratley MH, Nolan PJ, Jor-gensen GI. A method of studying adaptive changes of the oro-pharynx to variation in mandibular position in patients with obstructive sleep apnoea. J Oral Rehabil 1996; 23(10): 699−711.

Fritsch KM, Iseli A, Russi EW, Bloch KE. Side effects of man-dibular advancement devices for sleep apnea treatment. Am J Respir Crit Care Med 2001; 164(5): 813−8.

Pantin CC, Hillman DR, Tennant M. Dental side effects of an oral device to treat snoring and obstructive sleep apnea. Sleep 1999; 22(2): 237−40.

Marklund M, Sahlin C, Stenlund H, Persson M, Franklin KA. Mandibular advancement device in patients with obstructive sleep apnea : Long-term effects on apnea and sleep. Chest 2001; 120(1): 162−9.

Marklund M, Franklin KA, Persson M. Orthodontic side-effects of mandibular advancement devices during treatment of snor-ing and sleep apnoea. Eur J Orthod 2001; 23(2): 135−44.

Bondemark L, Lindman R. Craniomandibular status and function in patients with habitual snoring and obstructive sleep apnoea after nocturnal treatment with a mandibular advancement splint: A 2-year follow-up. Eur J Orthod 2000; 22(1): 53−60.

Rose EC, Staats R, Virchow C, Jonas IE. Occlusal and skeletal ef-fects of an oral appliance in the treatment of obstructive sleep apnea. Chest 2002; 122(3): 871−7.

FDA Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guid-ance for Industry and FDA. 2013. Available from: https://www.accessdata.fda.gov/.../cfdocs/.../classi.

American Sleep Disorders Association. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral ap-pliances. Sleep 1995; 18(6): 511−3.

Pitsis AJ, Darendeliler AM, Gotsopoulos H, Petocz P, Cistulli PA. Effect of vertical dimension on efficacy of oral appliance ther-apy in obstructive sleep apnea. Am J Respir Crit Care Med 2002; 166(6): 860−4.